Loading...

Lillian Cruz-Orengo

TitleASST PROF-SFT-VM
InstitutionUniversity of California Davis
DepartmentVM: ANAT PHYSIO & CELL BIOLOGY
Address1089 Veterinary Medicine Dr. 2019 VM3b
CA 95616
Phone530-752-7318
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Daniels BP, Holman DW, Cruz-Orengo L, Jujjavarapu H, Durrant DM, Klein RS. Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals. MBio. 2014 Aug 26; 5(5):e01476-14. PMID: 25161189; PMCID: PMC4173776.
    2. Cruz-Orengo L, Daniels BP, Dorsey D, Basak SA, Grajales-Reyes JG, McCandless EE, Piccio L, Schmidt RE, Cross AH, Crosby SD, Klein RS. Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility. J Clin Invest. 2014 Jun; 124(6):2571-84. PMID: 24812668; PMCID: PMC4089451.
    3. Daniels BP, Cruz-Orengo L, Pasieka TJ, Couraud PO, Romero IA, Weksler B, Cooper JA, Doering TL, Klein RS. Immortalized human cerebral microvascular endothelial cells maintain the properties of primary cells in an in vitro model of immune migration across the blood brain barrier. J Neurosci Methods. 2013 Jan 15; 212(1):173-9. PMID: 23068604; PMCID: PMC3641664.
    4. Cruz-Orengo L, Chen YJ, Kim JH, Dorsey D, Song SK, Klein RS. CXCR7 antagonism prevents axonal injury during experimental autoimmune encephalomyelitis as revealed by in vivo axial diffusivity. J Neuroinflammation. 2011 Dec 06; 8:170. PMID: 22145790; PMCID: PMC3305694.
    5. Cruz-Orengo L, Holman DW, Dorsey D, Zhou L, Zhang P, Wright M, McCandless EE, Patel JR, Luker GD, Littman DR, Russell JH, Klein RS. CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J Exp Med. 2011 Feb 14; 208(2):327-39. PMID: 21300915.
      View in: PubMed
    6. Cruz-Orengo L, Dhaka A, Heuermann RJ, Young TJ, Montana MC, Cavanaugh EJ, Kim D, Story GM. Cutaneous nociception evoked by 15-delta PGJ2 via activation of ion channel TRPA1. Mol Pain. 2008 Jul 31; 4:30. PMID: 18671867; PMCID: PMC2515828.
    7. Cruz-Orengo L, Figueroa JD, Torrado A, Puig A, Whittemore SR, Miranda JD. Reduction of EphA4 receptor expression after spinal cord injury does not induce axonal regeneration or return of tcMMEP response. Neurosci Lett. 2007 May 11; 418(1):49-54. PMID: 17418490; PMCID: PMC2570091.
    8. Cruz-Orengo L, Figueroa JD, Velázquez I, Torrado A, Ortíz C, Hernández C, Puig A, Segarra AC, Whittemore SR, Miranda JD. Blocking EphA4 upregulation after spinal cord injury results in enhanced chronic pain. Exp Neurol. 2006 Dec; 202(2):421-33. PMID: 16959251.
      View in: PubMed
    9. Irizarry-Ramírez M, Willson CA, Cruz-Orengo L, Figueroa J, Velázquez I, Jones H, Foster RD, Whittemore SR, Miranda JD. Upregulation of EphA3 receptor after spinal cord injury. J Neurotrauma. 2005 Aug; 22(8):929-35. PMID: 16083359.
      View in: PubMed
    10. Marie B, Cruz-Orengo L, Blagburn JM. Persistent engrailed expression is required to determine sensory axon trajectory, branching, and target choice. J Neurosci. 2002 Feb 01; 22(3):832-41. PMID: 11826113.
      View in: PubMed
    11. Willson CA, Irizarry-Ramírez M, Gaskins HE, Cruz-Orengo L, Figueroa JD, Whittemore SR, Miranda JD. Upregulation of EphA receptor expression in the injured adult rat spinal cord. Cell Transplant. 2002; 11(3):229-39. PMID: 12075988.
      View in: PubMed